EDTA Scientific Study Data -- 100 Studies
Compiled by
Karl Loren
Words in title only: EDTA
Published in 1977 through 1999
Only select references with abstracts available
Show references published in English only
Show references pertaining to humans
Documents: 1 to 100 of 309
Top
| Number |
Title |
Comments |
| ...1... |
|
|
| ...2... |
|
|
| ...3... |
|
|
| ...4... |
|
|
| ...5... |
|
|
| ...6... |
|
|
| ...7... |
|
|
| ...8... |
|
|
| ...9... |
|
|
| ...10... |
|
|
| Menu Position #10 | ||
| ...11... |
|
|
| ...12... |
|
|
| ...13... |
|
|
| ...14... |
|
|
| ...15... |
|
|
| ...16... |
|
|
| ...17... |
|
|
| ...18... |
|
|
| ...19... |
|
|
| ...20... |
|
|
| Menu Position #20 | ||
| ...21... |
|
|
| ...22... |
|
|
| ...23... |
|
|
| ...24... |
|
|
| ...25... |
|
|
| ...26... |
|
|
| ...27... | Lead exposure and accumulation in healthy Thais: assessed by lead levels, EDTA mobilization and heme synthesis-related parameters. | |
| ...28... |
|
|
| ...29... |
|
|
| ...30... |
|
|
| Menu Position #30 | ||
| ...31... |
|
EDTA chelation therapy is safe, effective, and more economical than commonly used surgical treatments for vascular disease. This article includes evidence of effectiveness, mechanisms of action of EDTA, a discussion of studies that have been done regarding the therapy, and some brief case reports. The conclusion is that EDTA chelation therapy should be a therapeutic option for vascular disease, either by itself or in conjunction with standard protocols. |
| ...32... |
|
|
| ...33... |
|
|
| ...34... |
|
|
| ...35... |
|
|
| ...36... |
|
|
| ...37... |
|
|
| ...38... |
|
|
| ...39... |
|
|
| ...40... |
|
|
| Menu Position #40 | ||
| ...41... |
|
|
| ...42... |
|
|
| ...43... |
|
|
| ...44... |
|
|
| ...45... |
|
|
| ...46... |
|
|
| ...47... |
|
We conclude that P/S ratios vary by analytical methods, and that HDLC ratios tend to be larger in magnitude and in the opposite direction from TC and TG. Both effects lead to significant biases in computed disease risk. |
| ...48... |
|
|
| ...49... |
|
|
| ...50... |
|
|
| Menu Position #50 | ||
| ...51... |
|
|
| ...52... |
|
|
| ...53... |
|
|
| ...54... |
|
|
| ...55... |
|
|
| ...56... |
|
|
| ...57... |
|
|
| ...58... |
|
|
| ...59... |
|
|
| ...60... |
|
|
| Menu Position #60 | ||
| ...61... |
|
|
| ...62... |
|
|
| ...63... |
|
These results suggest that 15% EDTA solution is more effective than saline solution as a root canal irrigant. |
| ...64... |
|
|
| ...65... |
|
|
| ...66... |
|
|
| ...67... |
|
|
| ...68... |
|
|
| ...69... |
|
|
| ...70... |
|
|
| Menu Position #70 | ||
| ...71... |
|
|
| ...72... |
|
|
| ...73... |
|
Sixty patients with intermittent claudication participated in a double-blind placebo-controlled trial of 20 courses of intravenous chelation therapy with 3 g of disodium EDTA vs placebo during 5-9 weeks. After the first infusion, the 24-h urinary excretion of lead and zinc was approximately 25-fold higher in the EDTA-treated group; relative differences for copper and calcium were smaller. Urinary magnesium excretion in the EDTA-treated group was one-third less than in the control group. After the treatment period, the blood lead concentration had decreased by approximately 73% and the serum zinc concentration by approximately 34%; other changes in blood concentrations were negligible. The loss of essential minerals and the possible redistribution of lead in the body may constitute a disadvantage that should be taken into account in repeated intravenous EDTA treatment. |
| ...74... |
|
|
| ...75... |
|
|
| ...76... |
|
|
| ...77... |
|
|
| ...78... |
|
|
| ...79... |
|
|
| ...80... |
|
Ethylenediamine tetraacetic acid (EDTA) chelation therapy has been used for decades for the treatment of vascular disease, alone or in combination with other treatments. This article includes a historic review of the research literature, current evidence of effectiveness, potential mechanisms of action of EDTA, and some brief case reports. The authors conclude that EDTA chelation therapy is a valuable therapeutic option for vascular disease, either alone or in conjunction with standard treatment protocols. |
| Menu Position #80 | ||
| ...81... |
|
|
| ...82... |
|
|
| ...83... |
|
|
| ...84... |
|
|
| ...85... |
|
|
| ...86... |
|
|
| ...87... |
|
|
| ...88... |
|
|
| ...89... |
|
Both intravenously administered EDTA and an orally administered alternative proved to be effective in removing lead from the body. |
| ...90... |
|
|
| Menu Position #90 | ||
| ...91... |
|
|
| ...92... |
|
|
| ...93... |
|
|
| ...94... |
|
|
| ...95... |
|
Ethylenediaminetetraacetate (EDTA) is known to bind zinc (Zn) and other metals. [It will bind these metals IN THE GUT as well as in the blood. Thus, when the EDTA is taken orally, it WILL bind metals, thus its use here. There is no inference that this EDTA was to bind metals in the blood.] EDTA-washed soy protein-based diet has been extensively used as a dietary model for the production of Zn-deficiency in human subjects as well as in experimental animals. |
| ...96... |
|
|
| ...97... |
|
|
| ...98... |
|
|
| ...99... |
|
|
| ...100.. |
|
|
Record 1 from database: MEDLINE
Return
To Top
Return
To Top
Return
To Menu Position #10
Record 2 from database: MEDLINE
Return
To Top
Record 3 from database: MEDLINE
Return
To Top
Record 4 from database: MEDLINE
Return
To Top
Record 5 from database: MEDLINE
Return
To Top
Record 6 from database: MEDLINE
Return
To Top
Record 7 from database: MEDLINE
Return
To Top
Record 8 from database: MEDLINE
Return
To Top
Record 9 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Top
Return
To Menu Position #10
Record 10 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Top
Return
To Menu Position #10
Record 11 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Top
Return
To Menu Position #10
Record 12 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Top
Return
To Menu Position #10
Record 13 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Top
Return
To Menu Position #10
Record 14 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Top
Return
To Menu Position #10
Record 15 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Top
Return
To Menu Position #10
Record 16 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Top
Return
To Menu Position #10
Record 17 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Top
Return
To Menu Position #10
Record 18 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Top
Return
To Menu Position #10
Record 19 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Menu Position #20
Return
To Top
Return
To Menu Position #10
Return
To Menu Position #20
Record 20 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Menu Position #20
Return
To Top
Return
To Menu Position #10
Return
To Menu Position #20
Record 21 from database: MEDLINE
Return
To Top
Return
To Menu Position #10
Return
To Menu Position #20
Return
To Top
Return
To Menu Position #20
Record 22 from database: MEDLINE
Return
To Top
Return
To Menu Position #20
Return
To Top
Return
To Menu Position #20
Record 23 from database: MEDLINE
Return
To Top
Return
To Menu Position #20
Return
To Top
Return
To Menu Position #20
Record 24 from database: MEDLINE
Return
To Top
Return
To Menu Position #20
Return
To Top
Return
To Menu Position #20
Record 25 from database: MEDLINE
Return
To Top
Return
To Menu Position #20
Return
To Top
Return
To Menu Position #20
Record 26 from database: MEDLINE
Return
To Top
Return
To Menu Position #20
Return
To Top
Return
To Menu Position #20
Record 27 from database: MEDLINE
Return
To Top
Return
To Menu Position #20
Return
To Top
Return
To Menu Position #20
Record 28 from database: MEDLINE
Return
To Top
Return
To Menu Position #20
Return
To Top
Return
To Menu Position #20
Record 29 from database: MEDLINE
Return
To Top
Return
To Menu Position #20
Return
To Top
Return
To Menu Position #20
Record 30 from database: MEDLINE
Return
To Top
Return
To Menu Position #20
Return
To Menu Position #30